You are here: Business & Industry Production & Manufacturing

Production & Manufacturing

Galena Biopharma Acquires Mills Pharmaceuticals

E-mail Print PDF

Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced it has acquired Mills Pharmaceuticals, which has the worldwide rights to GALE-401 (Anagrelide CR), a patented, controlled release formulation of anagrelide.

Bayer HealthCare launches oncology treatment Xofigo in UK

E-mail Print PDF

Bayer HealthCare has launched Xofigo (radium - 223 dichloride) solution for injection in the UK to treat adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.

PharmaCell signs deal to produce Dendreon' Provenge in Europe

E-mail Print PDF

Netherlands-based PharmaCell has entered into an agreement with Dendreon to be the contract manufacturing organization (CMO) for the European commercial production of its recently approved cellular immunotherapy product Provenge dispersion for infusion.

Aspen proposes to acquire GSK's thrombosis brands and NDB site

E-mail Print PDF

Research-based pharmaceutical and healthcare company GlaxoSmithKline (GSK) has received a proposal from Aspen Global and Aspen Pharmacare Holdings for its thrombosis brands and Notre-Dame de Bondeville (NDB) site.

Medicago wins European patent for influenza virus-like particles in plants

E-mail Print PDF

The European Patent Office (EPO) has granted Medicago a patent protecting exclusive rights to produce influenza virus-like particles (VLPs) in plants through July 2028.

Bionomics commences BNC10 manufacturing activities

E-mail Print PDF

Australia-based international biotechnology company Bionomics has commenced manufacturing activities for anti-cancer stem cell candidate BNC10.

DSM, DecImmune collaborate to develop N2 pathway blocking antibody

E-mail Print PDF

DSM Pharmaceutical Products has entered into collaboration with venture capital funded DecImmune Therapeutics of Cambridge, US.

Sunshine looking for CMOs for breast cancer drug Adva-27a manufacturing

E-mail Print PDF

Sunshine Biopharma has started discussions with contract manufacturing organizations (CMOs) for the production of its multidrug-resistant breast cancer drug, Adva-27a.

Qualicaps to invest $26m for Whitsett facility expansion

E-mail Print PDF

Pharmaceutical manufacturer Qualicaps will invest $26m to expand its facility in Whitsett, North Carolina in the US.

Bone Therapeutics to build new manufacturing facility in Belgium

E-mail Print PDF

Biopharmaceutical company Bone Therapeutics has announced that it has made a €10m investment in Skeletal Cell Therapy Support (SCTS) to build a new manufacturing facility at Gosselies Scientific Park near Brussels in Belgium.

Page 1 of 5

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  Next 
  •  End 
  • »